课题基金 / 基金详情

Gene Expressions of Urokinase-type Plasminogen Activator and Plasminogen Activator Inhibitor-2

Gene Expressions of Urokinase-type Plasminogen Activator and Plasminogen Activator Inhibitor-2
尿激酶型纤溶酶原激活剂和纤溶酶原激活剂抑制剂2的基因表达
批准号:
06671079
负责人:
NIIYA Kenji
金额:
$1.22万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995

项目摘要

项目成果

NIIYA Kenji的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
I have investigated the effects of phrobol myristate acetate (PMA), an activator of protein kinase C,cAMP and cytokines on urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor-2 (PAI-2) in RC-K8 lymphoma and PL-21 leukemia cell lines. The results show that cANP decreases uPA production in RC-K8 cells through suppressing uPA gene transcription and in which de novo protein synthesis is not necessary, and it is dependent of protein kinase activity (BBA 1268,1995). Treatment of RC-K8 cells with Beraprost, a stable analogue of prostaglandin 12, resulted in a decrease of uPA mRNA (Thromb Haemost, 1996, in press). IL-1 type I receptor is present on the RC-K8 cell-surface, and both IL-1alpha, beta induce uPA gene transcription in the cells (Thromb Haemost 74,1995). Elecromobility shift assay using the double stranded AP1 oligo revealed the presence of TPA-response element binding proteins (TREB) in RC-K8 cells and the TREB was increased by stimulation with PMA, but no … More t with IL-1, suggesting the TREB may be involved in RMA-induced uPA expression. Both cAMP and PMA can induce PAI-2 in PL-21 cells but the signal transduction pathways after cAMP and PMA stimulation ares different, although there must be a crosstalk between two pathways (Thromb Haemost 72,1994). A couple of TREB are present in PL-21 cells and the inhibitory effect of antisense S oligo against c-fos cDNA on PMA-induced PAI-2gene expression was demonstrated by RT-PCR method. Lipopolysaccharide (LPS) induced uPA and PAI-2 in RC-K8 and PL-21 cells, respectively. LPS induces uPA independently of the IL-1 pathway (Thromb Haemost 74,1995). Interestingly, CD14 which is believed to be a LPS-receptor is not present on the PL-21 cell surface, therefore LPS might induce uPA through the unknown pathway. To investigate these uPA and PAI-2 gene expression in malignant cells which are still not fully understood, collaboration study with Friedrich Miescher Institute in Switzerland will start in this year. Less
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
Nomura N,Niiya K,: "Inhibitory effect of a synthetic prostacyclin analogue, Beraprost,." Thromb Haemost. in press (1996)
Nomura N,Niiya K,:“合成前列环素类似物贝前列素的抑制作用。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hayakawa Y,Tazawa S,Ishikawa T,Niiya K,Sakuragawa N: "Transcriptional Regulation of Tissue-and Urokinase-type Plasminogen Activator Genes by Thrombin in Human Fetal Lung Fibroblasts" Thromb Haemost. 74 (2). 704-710 (1995)
Hayakawa Y、Tazawa S、Ishikawa T、Niiya K、Sakurakawa N:“人类胎儿肺成纤维细胞中凝血酶对组织和尿激酶型纤溶酶原激活剂基因的转录调节”血栓 Haemost。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shinbo M,Miiya K,Al-mokdad M,Hayakawa Y,Hiraga K,Fujimaki M,Sakuragawa N: "Protein Kinase Activity-dependent Inhibition of Urokinase-type Plasminogen Activator Gene Transcription by cyclic AMP in Human Pre-B Lymphoma Cell Line RC-K8" Biochim Biophy Acta.
Shinbo M、Miiya K、Al-mokdad M、Hayakawa Y、Hiraga K、Fujimaki M、Sakurakawa N:“环 AMP 在人 Pre-B 淋巴瘤细胞系 RC 中对尿激酶型纤溶酶原激活剂基因转录的蛋白激酶活性依赖性抑制
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Niiya K,Shinbo M,Ozawa T,Hayakawa Y,Sakuragawa N: "Modulation of Urokinase-type Plasminogen Activator Gene Expression by Inflammatory Cytokines in Human pre-B Lymphoma Cell Line RC-K8" Thromb Haemost. 74 (6). 1511151-5 (1995)
Niiya K、Shinbo M、Ozawa T、Hayakawa Y、Sakurakawa N:“人前 B 淋巴瘤细胞系 RC-K8 中炎症细胞因子对尿激酶型纤溶酶原激活剂基因表达的调节”血栓 Haemost。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
18
    INHIBITION OF INVASIVENESS AND METASTATIC POTENTIAL OF HUMAN PE-B LYMPHOME CELLS BY INHIBITING UROKINASE EXPRESSIN
    The Structure and the Function of Plasminogen Activator Inhibitor 2
    • 批准号:
      02671129
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.6万
    • 财政年份:
      1990
    • 负责人:
      NIIYA Kenji
    • 依托单位:
    国内基金
    海外基金
    Circ-ZEB1.33/MAGED4介导PAI-2泛素化参与ECM重塑促胶质瘤进展的机制
    • 批准号:
      --
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      33万元
    • 批准年份:
      2022
    • 负责人:
      张庆梅
    • 依托单位:
    miR-200/PAI-2信号通路对小细胞肺癌CTC的调控机制及其与转移的相关性研究
    • 批准号:
      81660394
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      37.0万元
    • 批准年份:
      2016
    • 负责人:
      金铁峰
    • 依托单位:
    纤溶酶原激活物抑制剂2(PAI-2)抑制肝细胞癌侵袭转移的作用机制及作为体内调控靶点的相关研究
    HeLa细胞凋亡中与PAI-2和tTG相互作用蛋白质的筛选
    • 批准号:
      30070412
    • 项目类别:
      面上项目
    • 资助金额:
      16.0万元
    • 批准年份:
      2000
    • 负责人:
      朱运松
    • 依托单位: